12 | $SOBR on the BO>2.1 had vol which sold of | znewcar1 | 09/28/2022 12:55:48 PM |
11 | SOBR interesting pop HOD2.21 got S@1.7's a BO2.1 ![]() |
znewcar1 | 09/28/2022 12:25:40 PM |
10 | $SOBR perkulating @ 2 | znewcar1 | 09/28/2022 12:22:46 PM |
9 | $SOBR HOD2.21 got S@1.7 retesting1.9 a BOD2 could | znewcar1 | 09/28/2022 11:49:56 AM |
8 | SOBR 232% v22,3M c3.03 f10,9M H3.16 YL.847 gapup | znewcar1 | 09/20/2022 10:55:44 PM |
7 | SOBR 25% v2,5M c1.43 f10,9M H1.74 note Fwas152M | znewcar1 | 08/08/2022 5:44:11 PM |
6 | SOBR reverse split, 4/28/2022: 1:3 | Steel Reserve | 04/28/2022 3:30:22 PM |
5 | IMLE 53% v1,7M c.0199 f152M | znewcar1 | 09/17/2019 4:13:31 PM |
4 | IMLE Financials 07/16/2014 10:15:02 TransBiotec, | Emylers | 07/16/2014 11:14:58 AM |
3 | Latest Imagine Media Ltd. (IMLE) Headlines OTC | Stock_Tracker | 03/10/2014 6:15:53 AM |
2 | IMLE 0.02 Stock Charts $IMLE 1 Month Chart | chartguy89 | 03/07/2014 10:38:14 PM |
1 | IMLE Stock Charts Last: +0.0018 Thursday, | chartguy89 | 02/27/2014 2:26:53 AM |
Recent Articles
- Investing in Education for a Sustainable Peaceful Future
- Blumenthal Nordrehaug Bhowmik De Blouw LLP Takes Action Against Greenwaste Recycling
- Soshiro Hoshina Joins Kaiju No. 8 Game: Exciting New Update
- The $100,000 H-1B Visa Fee: Implications on Tech Giants
- Teva's Olanzapine LAI Study Highlights Safety and Efficacy
- AUSTEDO XR: Improving Lives Through Symptom Management
- Teva's New Olanzapine LAI Offers Long-Term Safety for Schizophrenia
- Floyd Mayweather Jr. Faces $1.2M Lawsuit From Vegas Auto Gallery
- Elon Musk Envisions a Future with Robot-Empowered Abundance
- Reflections on Leadership and Change in America Today
- A Historic Week of Changes and Challenges in America
- Freedom Plaza's Vision: A Transformational Affordable Housing Project
- MTL Cannabis Corp. Secures $2 Million in Recent Offering
- Freedom Plaza Pledges Complete Affordable Housing Commitment
- Fluor Corporation Faces Securities Class Action – Investors Alert
- Ex-Trump Lawyer Compares Kimmel Suspension to Historical Censorship
- The Speedy Job Hunt: How Fast Applications Led to Success
- Exploring the Decline in Donald Trump's Approval Ratings
- Strategic Shifts in AI: How Trump's Actions Redefine America
- MAGACOIN FINANCE Surges with Impressive Presale Success
- Revolutionizing Trading with Bravo Flowdex: A 2025 Perspective
- Discover Bravo Flowdex: Your AI Trading Solution in 2025
- Unlocking Trading Potential with Next-Gen Net Rowdex AI
- Ricardo Salinas Pliego's Bold Bitcoin Stance Against Fiat
- Kiyosaki Critiques Funds, Supports Trump's Move for Investors
- MAGACOIN FINANCE Emerges as a Significant Player in Crypto
- Unveiling the Cutting-Edge Technology of Immediate Edge Trading
- uCloudlink Launches PetPhone to Revolutionize Pet Care
- Investors Invited to Join Securities Fraud Lawsuit against SPPI
- Charlie Kirk's Final Thoughts on Success and Entrepreneurship
- Tracer's Innovative IEO Launch on Coinstore Revolutionizes Carbon Market
- Goldragon Transforms GameFi with Innovative Staking and Governance
- Convenience Stores Challenge Fast-Food Chains for Breakfast Sales
- Essential Guidance for Families in Interpleader Lawsuits
- Sasken and VicOne Unite for Cutting-Edge Automotive Security
- Investors Can Lead Tronox Holdings plc Class Action Lawsuit
- Investors Review V.F. Corporation Class Action Lawsuit Insights
- Sasken and VicOne Unite for Advanced Automotive Security Solutions
- A Deep Dive into AI Growth and Its Impact on Industries
- Trump's Shift on Taiwan Military Support: Implications Ahead
- Navigating the Frontier of Artificial Superintelligence
- Discover AIMOON: A New Era in AI and Web3 Interactions
- Investors of V.F. Corporation Can Pursue Class Action Claims
- Farm Aid 40: Honoring Legacy and Addressing Future Challenges
- Flying Taxi Market Warriors: Who Will Dominate the Sky?
- VAPORESSO's XROS PRO 2: A New Era for Vaping Excellence
- Senate Standoff: Shifting Dynamics and Government Shutdown Risk
- Celebrating Heritage: Spencer Tunick's Art for 100 Years of Alhambra
- VAPORESSO Unveils Cutting-Edge XROS PRO 2 for Vaping Enthusiasts
- C4 Therapeutics Unveils Exciting Cemsidomide Data for Myeloma